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Summary 
The Ku autoantigen is a heterodimer of 70- and 80-kD proteins recognized by autoantibodies 
from patients with systemic lupus erythematosus  and related diseases that is the DNA-binding 
component of a DNA-dependent protein kinase. The catalytic activity of DNA-dependent protein 
kinase is carried by a 350-kD subunit (p350). In light of the recently described role of Ku in 
repairing double-strand  DNA breaks, we investigated the regulation of Ku and p350 levels in 
neutrophils, a terminally differentiated cell type destined to undergo apoptosis. Since the appearance 
of double-strand DNA breaks is characteristic of apoptosis, we were interested in the possibility 
that Ku might oppose programmed cell death. Analysis of peripheral blood cells by flow cytometry 
using anti-Ku and anti-p350  monoclonal antibodies revealed that neutrophils were unstained, 
whereas resting (GO) lymphocytes were positive. The absence of Ku in mature neutrophils  was 
confirmed by Western blotting and enzyme-linked immunosorbent assay for Ku antigen. In contrast, 
the human promyelocytic  leukemia line, HL-60, which undergoes differentiation toward neutrophils 
after dimethylsulfoxide  treatment, was positive for Ku and p350. In view of the short lifespan 
of neutrophils and the prolonged half-life of Ku and p350  (>5 d), these data suggested  that 
Ku was actively degraded during myeloid differentiation. Analysis of HL-60 cells  by flow cytometry 
revealed that Ku staining was bimodal. Cells in G1/G0,  S, or G2/M were all stained positively, 
whereas cells with a subdiploid DNA content characteristic of apoptosis were Ku negative. Similar 
results were obtained with phytohemagglutin-stimulated  human lymphocytes. These data suggest 
that the Ku antigen is actively degraded in both myeloid cells destined  to undergo apoptosis 
and apoptotic lymphocytes, raising the possibility that degradation of Ku may help to prevent 
the inappropriate  repair of fragmented nuclear DNA during apoptosis. 
T 
he Ku autoantigen is a heterodimer of 70- and 80-kD 
proteins (p70 and p80, respectively) recognized by auto- 
antibodies  from sera of certain patients  with scleroderma- 
polymyositis overlap syndrome, SLE, and related diseases (1, 
2). Ku is the DNA-binding component of a DNA-dependent 
protein kinase, the catalytic activity of which is carried by 
a 350-kD protein (p350) (3-5). DNA-dependent protein kinase 
phosphorylates  a variety of DNA-binding proteins in vitro 
(6, 7), although its substrates in vivo are not yet well defined. 
Eukaryotic cells with a mutant p80 subunit have been shown 
recently to be defective in double-strand  DNA break repair 
and V(D)J recombination (8-11). 
In addition to its role in repairing double-strand  DNA 
breaks,  the Ku antigen may play a role in regulating cell 
proliferation (12-14). Charge variants of the p70 and pS0 pro- 
teins have  been described, and the levels of these variants de- 
pend on the cell's proliferative state (12, 13). Moreover, p70 
and p80 gene expression is increased during mitogen-induced 
activation of quiescent (GO) human lymphocytes to a prolifer- 
ative state, and it is inactivated  by phorbo| ester-induced mono- 
cytic differentiation of HL-60 cells (15). However, despite dra- 
matic changes in Ku mRNA expression, the total level of 
Ku has been reported to be similar in quiescent and prolifer- 
ating cells, possibly  because the antigen is highly stable (12-15). 
In the present study, we report that, although the promyelo- 
cytic leukemia cell line HL-60 and PBLs are positive, mature 
peripheral blood neutrophils and apoptotic lymphocytes con- 
tain no detectable Ku antigen.  The absence of Ku in these 
cells may reflect active degradation before or during apoptosis. 
Materials and Methods 
Preparation of PBLs and Neutrophils.  Blood  samples were ob- 
tained from healthy volunteers, and lymphocytes  and neutrophils 
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periments, monocytes were depleted by incubating the cell suspen- 
sion in plastic  dishes for 1 h at 37~  in RPMI  1640/10%  fetal 
bovine serum and collecting the nonadherent cells (17). In other 
experiments, peripheral blood nucleated cells were separated by dex- 
tran sedimentation followed by hypotonic RBC lysis and Ficoll- 
Hypaque gradient centrifugation (17). Purity of the cell popula- 
tions was determined by staining with antibodies specific for CD16 
(neutrophils and NK cells) or CD3 (T cells) (see below). Cell via- 
bility was >90% by trypan blue exclusion. 
Cell  Lines  and  mAbs.  The  HL-60  (human  promyelocytic 
leukemia) and K562 (human erythroleukemia) cell lines were ob- 
tained from the American Type Culture Collection (Rockvitle, MD) 
and  maintained  in  RPMI  1640/10%  fetal bovine  serum  sup- 
plemented with t-glutamine and penicillin/streptomycin. Murine 
anti-Ku mAbs 162 (IgG2a anti-p70/p80 dimer [2, 18]), 111 (IgG1 
anti-pS0  [2, 19]), and N3H10 (IgG2b anti-p70 [19, 20]) were de- 
scribed previously. Murine anti-p350 mAb 25-4 was kindly provided 
by Dr. Timothy Carter (St. John's University, Jamaica, NY) (4). 
Polyclonal rabbit anti-p350 serum was a gift from Dr. Carl An- 
derson (Brookhaven National Laboratory, Upton, NY) (3). Purified 
murine anti-human CD3 (SK7,  IgG1) and CD16 (GO22, IgM) 
mAbs were purchased from Becton Dickinson and Co. (Mountain 
View,  CA).  Murine  mAb  BM6.5  is  an  IgG2a  antihistone  H1 
(Rapoport, R. G., ]3. Kotzin, and P. L. Cohen, unpublished data). 
Murine mAb Y2 (IgG2a anti-Sm B'/B and D) was provided by 
Dr. Joan Steitz (Yale University, New Haven, CT) (21). mAb PAb 
101 (TIB 117, murine IgG2a anti-SV40 large T antigen; American 
Type Culture Collection) was used as an isotype control. 
Determination of  Ku Half-life.  K562 cells were pulse labeled with 
[35S]methionine  and  cysteine  (DuPont/New  England  Nuclear, 
Boston, MA) as described previously (15). Briefly, 1.4  x  107 cells 
were washed twice with PBS, preincubated for 30 min in 2 ml 
of methionine-free RPMI 1640 containing 10% PBS-dialyzed fetal 
bovine serum, and labeled for 15 min at 37~  by adding 1.5 mCi 
of [3SS]methionine and cysteine. After pulse labeling, 45 ml of ice- 
cold tLPMI 1640 was added, and the cells were collected by cen- 
trifugation and washed with PBS. 1 aliquot of pulse-labeled  cells 
(2  x  106 cells) was harvested immediately, and the remaining ali- 
quots of cells were cultured at 37~  in five tissue  culture flasks 
containing 5 ml of complete medium. One flask (2  x  106 cells) 
was harvested after 1, 2, 3, 4, and 5 d  of chase.  The cells were 
washed once with PBS and frozen. The cells were later thawed 
and sonicated  in 0.15 M NaC1 NET/NP-40 (0.5 M NaC1, 2 mM 
EDTA, 50 mM Tris-HC1, pH 7.5,  0.3%  NP-40). Extracts were 
cleared  by  centrifugation,  and  lysates  derived  from  5  x  l0  s 
starting cells (i.e., at the time of pulse labeling) were immunopre- 
cipitated with 5/xl of mAbs 162, 111, or N3H10 ascitic fluid, or 
with 30 BI of 25-4 culture supernatant as described (15, 18). Im- 
munoprecipitates were washed  three times with  0.15  M  NaC1 
NET/NP-40 buffer and once with NET buffer alone, and analyzed 
by SDS-PAGE. Gels were fluorographed and bands were quantified 
using a Phosphorlmager with Image Quant software (Molecular 
Dynamics, Inc., Sunnyvale,  CA). 
PHA  Stimulation  of PBLs.  PBLs  were  separated  on  Ficoll- 
Hypaque gradients (17) and washed twice with PBS. The cells were 
depleted of  plastic adherent cells as above and resuspended in RPMI 
1640/10% fetal bovine serum with 10/xg/ml PHA (Gibco BILL, 
Gaithersburg, MD) in RPMI 1640. Cells were harvested 4 d later 
and analyzed by flow cytometry for DNA content and Ku antigen 
(see below). 
Immunoblotting.  Immunoblot analysis of p70 and p80 was per- 
formed using anti-Ku mAbs N3H10 and 111 (19) and cell extracts 
derived from equal numbers of neutrophils or PBLs. Briefly, the 
cells were sonicated in lysis buffer (2.5% SDS, 0.1 M dithiothre- 
itol, 50 mM Tris-HC1, pH 7.5) or in 0.01 M sodium phosphate, 
pH 7.2, 0.1 M dithiothreitol, 1% SDS, and 6 M urea containing 
protease inhibitors (0.5 mM PMSF, 0.5/~g/ml leupeptin, and 0.3 
trypsin inhibitor units/ml aprotinin, all from Sigma Chemical Co., 
St. Louis, MO), followed by SDS-PAGE and transfer of the pro- 
teins  to nitrocellulose membrane.  The blots were probed with 
N3H10 or 111 ascitic fluid (1:500), followed by washing and incu- 
bation with  1:1,000 alkaline phosphatase-conjugated goat anti- 
mouse IgG antibodies (Tago, Inc., Burlingame, CA) and substrate. 
Sandwich ELISAforKu  Antigen.  The ELISA for quantitating 
Ku antigen was described previously (2). Briefly, wells of 96-wetl 
polystyrene plates  (MaxiSorp;  Nunc,  Inc.,  Naperville, IL) were 
coated with 50/zl of,,ol0 #g/ml purified mAb 162 in 20 mM Tris 
buffer at pH 8.0 and incubated at 4~  for 16 h. After blocking 
the wells,  serial dilutions of cell lysates were added to the wells 
for 90 rain, followed by washing and incubation for 90 min with 
mAb 111 (1:500). The wells were again washed,  followed by incu- 
bation with  1:1,000 alkaline phosphatase--conjugated  goat anti- 
mouse IgG1 (3' chain-specific) antibodies (Southern Biotechnology 
Associates, Birmingham, AL). Substrate was added and absorbance 
was determined 45 min later at 405 nm using an ELISA reader 
(Molecular  Dynamics, Inc.). 
Analysis of DNA Content and Ku Antigen Level by Flow Cytom- 
etry.  Double staining for intracellular protein and DNA was per- 
formed as described (22, 23). Briefly, cells were washed twice with 
PBS and fixed with 70% methanol at  -20~  for 5 rain, and then 
washed three more times with PBS, resuspended in staining buffer 
(HBSS containing 3% fetal bovine serum, 15 mM Hepes, pH 7.3, 
and 0.1% sodium azide), and incubated for 15 rain. The cells were 
then incubated 45 rain with anti-Ku antibodies (1:100 ascitic fluid 
or 1:1 culture supernatant) and washed with HBSS, 0.5% fetal bo- 
vine serum, and 0.1% sodium azide, followed by 45 rain of incuba- 
tion with appropriate isotype-specific  FITC-labeled second anti- 
bodies (Southern Biotechnology Associates).  The cells were then 
washed again and fixed with 1% (wt/vol) paraformaldehyde in PBS. 
DNA content was determined by propidinm iodide (PI)  1 staining 
after treating the cells with ribonuclease A (Sigma Chemical Co.) 
(22, 23). FITC intensity in gates placed on G1, S, and G2/M regions 
of the DNA histogram was determined by flow cytometry using 
a FACSCAN  |  (Becton Dickinson and Co.) with data acquisition 
software (Cicero; Cytomation, Fort Collins, CO). In some experi- 
ments, HL-60 cells were double stained with PI plus mAb 162, 
BM6.5, Y2, or PAbl01 in the same manner. FITC gates were placed 
on the subdiploid region of the DNA histogram (apoptotic ceils), 
or on the G1, S, plus G2/M regions (nonapoptotic cells), and FITC 
fluorescence was plotted on a 4-decade  logarithmic scale. 
Analysis of Apoptotic Cells.  Apoptotic cells appeared in the <2N 
DNA peak  (24)  and were distinguished  from necrotic cells by 
analyzing the light scatter profile. Necrotic cell death resulted in 
a large drop in forward light scatter (fcs) and side scatter (ssc), 
whereas cell death by apoptosis  resulted in a smaller decline in fsc 
and an initial increase in ssc (25).  Samples were collected in list 
mode so that, when phenotypic markers were used, the percentage 
of cells undergoing apoptosis  could be determined by gating on 
FITC-stained cells and subsequently analyzing DNA staining. Data 
were plotted on a 4-decade  logarithmic scale, except for DNA 
1Abbreviations used in  this paper: fsc, forward light  scatter; PCNA, 
proliferating  cell nuclear antigen; PI, propidium iodide; ssc, side  light scatter. 
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collected per sample. 
Double Staining  for Surface Markers and Ku Antigen.  Cells  were 
frst stained for the surface markers CD3 or CD16 (1:100 for 45 
min on ice) using PE-conjugated isotype-specific  second antibodies 
and then fixed with 1% paraformaldehyde as above. The fixed cells 
were permeabilized by incubating for 30 min in 45% ethanol (22), 
stained for Ku as above  using FITC-conjugated isotype-specific  an- 
tibodies, and fixed for an additional 15 min in 1% paraformalde- 
hyde. The cells were then analyzed by flow cytometry as above. 
The specificities of the isotype-specific second antibodies were 
confirmed in all experiments. 
Results 
While examining the intracellular staining of human pe- 
ripheral blood nucleated cells with mAbs specific for the Ku 
antigen, we unexpectedly found that different cell popula- 
tions exhibited wide variations in the intensity of Ku staining. 
Of particular interest was an apparent lack of Ku in some 
cells. To identify this cell population, double staining experi- 
ments were performed. 
Lack of Ku Staining in Mature Human Neutrophils.  Prelim- 
inary analysis of fsc and ssc of the Ku-positive and -negative 
cell populations  suggested that these might correspond to 
lymphocytes and neutrophils, respectively (data not shown). 
That possibility was confirmed by double immunofluores- 
cent staining of purified neutrophils and lymphocytes (Fig. 
1). The neutrophil fraction after Ficoll-Hypaque gradient cen- 
trifugation was 96%  CD16 positive. Double staining with 
mAb 162 revealed that the CD16-positive cells did not stain 
for p70/p80  heterodimer (Fig.  1, left). Similar results were 
obtained  with  N3H10  (anti-p70)  and  111  (anti-pS0)  (not 
shown). Staining of PBLs with anti-CD3 (Fig.  1, right) re- 
vealed both positive and negative populations, as expected, 
consistent with the presence of T  cells and non-T cells (B 
lymphocytes plus monocytes and NK cells), respectively. Both 
the CD3 + (T) and CD3-  (non-T) cells stained positively 
with mAb 162, but the staining of CD3-  cells (primarily 
B lymphocytes and monocytes) was weaker than that of the 
CD3 + T  cells (Fig.  1, right).  The somewhat more hetero- 
geneous staining of non-T than T  cells by 162 may reflect 
the heterogeneity of the non-T cell population. 
These results indicated that the Ku-positive and -negative 
cell populations corresponded to lymphocytes (possibly along 
with monocytes and NK cells) and neutrophils, respectively. 
The lack of neutrophil Ku staining might be explained by 
a true absence of the antigen,  neutrophil-specific masking 
of Ku due to the binding of other nuclear antigens, or the 
loss of the Ku antigen from neutrophils, but not lympho- 
cytes, during fixation. To distinguish between these possibil- 
ities, neutrophils were purified and extracts of the cells were 
analyzed for the presence of Ku by Western blot and ELISA. 
Absence of Ku Antigen in Neutrophils.  For Western blot 
analysis, cell lysates from neutrophils or PBLs were fraction- 
ated by SDS-PAGE,  blotted onto nitrocellulose membrane, 
and probed with a mixture of anti-Ku mAbs N3H10 (anti- 
p70) and 111 (anti-pS0). The p70 and pS0 proteins were un- 
detectable in extracts derived from 0.5,  1.0,  or 2.0  x  106 
neutrophils (Fig. 2, lanes 2, 4, 6), but were readily detectable 
in extracts derived from the same numbers of PBLs (Fig. 2, 
lanes 1, 3, 5). Since the cells were lysed directly in buffer con- 
taining strong denaturants, the Western blot studies suggested 
that masking by other antigens was not responsil~le for the 
absence of Ku in neutrophils seen by flow cytometry (Fig. 
1). However, although the cell extracts used for Western blot- 
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Figure  1.  Staining of neutrophils and lymphocytes with anti-Ku mAb. Human neutrophils were stained for surface  expression  ofCD16 (mAb GO22, 
left), and lymphocytes were stained for surface expression of CD3 (mAb SK7, right)  followed by fixation, permeabilization, and staining for intracellular 
expression of Ku with mAb 162. Surface staining was detected using PE-conjugated goat anti-mouse IgG1 (to detect SK7) or IgM (to detect GO22) 
antibodies (y-axis).  Intracellular Ku staining was detected with FITC-conjugated goat anti-mouse  IgG2a antibodies (x-axis).  Staining was analyzed 
by two-color flow cytometry. 
2051  Ajmani et al. Figure  2.  Western blot analysis of Ku antigen in lymphocytes and neu- 
trophils.  Extracts  from 0.5 (lanes 1 and 2),  1.0 (lanes 3 and 4),  or 2.0 
(lanes 5 and 6)  x  106 cells were analyzed by SDS-PAGE and transferred 
to nitrocellulose. Blots were probed with a mixture ofmAbs N3HI0 (anti- 
p70) and 111 (anti-pS0), both at 1:500, followed  by alkaline  phosphatase-con- 
jugated goat anti-mouse IgG antibodies.  Lanes I, 3, and 5, human lym- 
phocyte  extract;  lanes 2,  4,  and 6,  human neutrophil extract.  Positions 
of p70 and p80  are indicated. 
ting were prepared by immediately  boiling cell pellets in buffer 
containing  1%  SDS,  6  M  urea,  and a cocktail of protease 
inhibitors, the possibility remained that proteases in the neu- 
trophil extract might have degraded Ku. That possibility was 
examined by mixing studies using a sandwich ELISA to quan- 
titate Ku antigen. As shown in Fig. 3, K562 cells contained 
high levels of Ku antigen (solid squares). A slight decrease in 
the Ku activity exhibited by K562 cell lysate was observed 
when nondenatured K562 and neutrophil cell lysates were 
mixed at a ratio of 1:1 in the presence of the same protease 
inhibitors used for Western blotting (open squares). However, 
neutrophil lysate by itself contained no detectable Ku antigen 
at all dilutions  tested (open circles). Resting PBLs  (solid tri- 
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Figure 3.  Quantitation of Ku antigen by sandwich ELISA. ELISA was 
performed  as described in Materials and  Methods.  Human cell extracts 
derived from 107-101 K562 cells (solid squares), HD60 cells (solid circles), 
lymphocytes  (solid triangles), or neutrophils  (open circles) were tested.  Ex- 
tract  from K562  cells was also mixed 1:1 with neutrophil  extract  (open 
squares) to evaluate whether proteases in the neutrophil extract degraded 
Ku in K562 lysate. In that case, cell number (x-axis) represents the number 
of K562  cell equivalents  added per well. 
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angles) contained somewhat less Ku on a per cell basis than 
proliferating K562 cells. The human promyelocytic  leukemia 
cell line HL-60,  which can be induced to differentiate to- 
ward neutrophils by DMSO treatment (26, 27), had a lower 
level of Ku than K562 cells (solid circles). However, the level 
of Ku in HL-60 was higher than that in resting PBLs,  and 
considerably higher than that in neutrophils. Taken together, 
the flow cytometry, Western blot, and ELISA data all indi- 
cated that Ku antigen was not present in mature neutrophils. 
Relationship  of Ku Staining  to DNA  Content.  Because of 
the presence of Ku antigen in resting PBLs and its absence 
in mature neutrophils, it seemed unlikely that the loss of Ku 
antigen was an attribute of GO cells in general. The relation- 
ship  between the level of Ku or p350  and position in the 
cell cycle was examined further by double staining PBLs with 
PI and mAbs 162 or 25-4,  respectively.  Staining of freshly 
isolated resting PBLs  with PI revealed a single population 
of  cells with G1/GO DNA content (Fig. 4, top). When PBLs 
were cultured for 4 d  in RPMI  1640  +  10%  fetal bovine 
serum (Fig.  4, middle),  the majority of the cells remained in 
G1/G0,  although small numbers of cells had S (8.9%)  or 
G2/M (9.5%) DNA content, and 9.3%  of the cells had a 
subdiploid DNA content typical of cells undergoing apop- 
tosis (24). Activation of the cells with PHA for 4 d increased 
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Figure  4.  DNA content of PBLs.  PI staining of freshly isolated PBLs 
(top), or PBLs cultured for 4 d in medium alone (4D-MED) or in medium 
containing PHA (4D-MED+PHA).  Cells in G1, S, and G2/M are indi- 
cated. The percentages of apoptotic  cells in resting  PBLs, PBLs cultured 
4 d in medium, and PBLs cultured 4 d in medium with PHA are shown. 
APO,  cells with subdiploid  DNA content characteristic  of apoptosis. 
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bottom). Mitogen activation also increased the number of apop- 
totic cells dramatically, as reported previously (28). Less than 
1% of fresh PBLs exhibited a subdiploid DNA content, com- 
pared with 9.3% of PBLs cultured for 4 d in medium alone 
and 31%  of cells cultured 4 d in medium plus PHA. 
Double staining of fresh PBLs, PBLs cultured for 4 d in 
medium alone, and PBLs grown in medium containing PHA 
is presented in Fig.  5 (A-C,  D-F,  and G-I,  respectively). 
Fresh PBLs all exhibited G1/G0 PI staining (Fig.  5, A-C) 
and were stained with mAbs 162 (anti-p70/pSO dimer, B) 
and 25-4 (anti-p350, C). After 4 d of in vitro culture in RPMI 
1640  +  10%  fetal bovine serum, nearly all PBLs remained 
positive for Ku (162 staining, compare E  and D) and p350 
(25-4  staining, compare F  and D).  Small numbers of cells 
with S or G2/M DNA content appeared after 4 d in culture, 
consistent with the weak mitogenic effect of fetal bovine 
serum. In addition, the intensity of both Ku and p350 staining 
in the G1/G0 population increased after 4 d in culture, sug- 
gesting that the levels of both Ku and p350 are higher in 
G1 lymphocytes than in resting (GO) lymphocytes (B-E and 
C-F,  respectively). 
PBLs  activated  for 4  d  with PHA  showed a strikingly 
different staining pattern. As shown in Fig. 5 G, PI staining 
revealed increased numbers of cells with S and G2/M DNA 
content, consistent with the data shown in Fig. 4. In addi- 
tion, a prominent population of cells with subdiploid DNA 
content was apparent after staining the mitogen-activated PBLs 
with PI (Fig.  5 G). Double staining of the PHA-activated 
cells with mAb 162 plus PI (Fig. 5 H) showed that the cells 
with G1, S, and G2/M DNA content were strongly positive 
for p70/pSO dimer, whereas the cells with a subdiploid DNA 
content failed to stain above background. Similarly,  PHA- 
activated PBLs in G1, S, and G2/M stained positively with 
anti-p350 mAb 25~  whereas the cells with subdiploid DNA 
content were negative (Fig.  5/).  These data indicated that 
both Ku antigen (p70/p80 heterodimer) and p350 were lost 
over a period of 4 d or less during apoptosis.  Since mature 
neutrophils are destined to undergo programmed cell death 
(29, 30), the lymphocyte staining data raised the possibility 
that the absence of Ku antigen in neutrophils might reflect 
their entry into an apoptosis pathway rather than terminal 
differentiation.  That  possibility was  addressed  by  double 
staining of ilL-60 cells, a Ku antigen-positive (Fig. 3) human 
promyelocytic leukemia cell line that undergoes a low level 
of spontaneous myeloid differentiation and apoptosis (27). 
Absence of Ku in Apoptotic HL-60 Cells.  As seen in the 
case of PHA-activated PBLs, analysis of the staining of HL- 
60 cells by anti-Ku mAb 162 in relationship to DNA con- 
tent by flow cytometry revealed the presence of Ku-positive 
and Ku-negative cell populations. Analysis offsc and ssc sug- 
gested the presence of two populations of HL-60 cells (Fig. 
6, top), one consisting of cells in G1, S, and G2/M (top right, 
population I) and showing greater relative fsc (top left, popu- 
lation I), and the other consisting largely of apoptotic cells 
with a subdiploid DNA content and exhibiting relatively less 
fsc (Fig. 6, top, population II). Staining of HL-60 with both 
anti-Ku (162) and PI showed a Ku-positive population corre- 
sponding to cycling (G1, S, and G2/M) cells (Fig. 6, bottom 
right, population I), and a Ku-negative population with sub- 
diploid DNA content characteristic  of apoptotic cells (24) 
(Fig. 6, bottom, compare population II with control). Fixa- 
tion with  paraformaldehyde revealed a  similar pattern  of 
staining, suggesting that the absence of Ku in apoptotic cells 
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Figure 5.  Level  of Ku and p350 in PBLs in relation- 
ship to DNA content. Freshly isolated PBLs (A-C), or 
PBLs grown in culture medium without (D-F) or with 
(G-/)  PHA  were  stained  for  DNA  content with  PI 
(x-axis).  The y-axis of A,/~ and G shows costaining of 
the cells with  FITC-conjugated  goat  anti-mouse IgG 
second antibody alone. The y-axis of/3, E, and H shows 
costaining with mAb 162 (anti-Ku, p70/p80 dimer) fol- 
lowed by the  FITC-conjugated  second antibody.  The 
y-axis of C, F, and I shows costaining  with mAb 25-4 
(anti-p350) followed  by the FITC-conjugated second anti- 
body Cells in GO, G1, S, and G2/M as well as cells with 
a  subdiploid  DNA content characteristic  of apoptosis 
(A/K)) are indicated in A, /3I and G. Figure  6.  Staining of cycling and apoptotic HL-60  cells for Ku. (Top) 
Analysis of fsc and ssc vs DNA content. (Left)  Analysis of fsc and ssc in 
Hb60 cells. (Right) DNA content of the same cells was determined by 
Pl staining. Cells with G1, S, and G2/M DNA content (population I) 
are shaded gray, and cells with subdiploid DNA content characteristic  of 
apoptosis (APO, population II) are shaded black. (Bottom) Staining with 
anti-Ku mAb. Hb60 cells were stained with second antibody alone (left, 
Control) or with PI plus anti-Ku mAb 162 (right). Ku staining of cell popu- 
lation I (G1, S, and G2/M DNA content) is indicated by gray shading. 
Ku staining of cell population 1I (subdiploid DNA content) is indicated 
by black shading. Note that Ku staining of population II is the same as 
seen with  second antibody alone, whereas Ku staining of population I 
is higher than that of control. 
was not due to looser binding to some nuclear structure and 
subsequent loss during fixation, as seen in the case of prolifer- 
ating  cell nuclear  antigen  (PCNA)  (31). 
To evaluate further the possibility that the decreased staining 
of Ku in apoptotic cells did not merely reflect leakage of nu- 
clear proteins from the permeabilized apoptotic cells, staining 
of HL-60 cells for histone H1 and for components of U  small 
nuclear ribonucleoproteins (the Sm B'/B and D  proteins) (32), 
was performed (Fig. 7). By gating on the subdiploid (apop- 
totic) cells, it was confirmed that staining with anti-Ku mAb 
162 was  no different than  that  of an  isotype control  (Fig. 
7, top left), whereas positive staining was found for both his- 
tone H1 (Fig.  7,  middle  left) and Sm antigen (Fig. 7,  bottom 
/eft).  Nonapoptotic cells stained brightly for Ku  (top  right) 
as  well as  histone  H1  (middle  right)  and  Sm  (bottom  right). 
The intensity of H1 and Sm staining was somewhat reduced 
in the apoptotic compared with nonapoptotic cells (compare 
Fig.  7,  left vs right,  middle,  and  bottom),  a finding which is 
consistent with the loss of some nuclear material in the form 
of apoptotic blebs (33). However, the complete loss of Ku, 
in contrast to the modest reduction of antihistone and anti- 
Sm staining, suggests that loss of Ku staining did not reflect 
a general "leakiness" of apoptotic cells. This interpretation 
was further supported by the staining of necrotic K562 cells 
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Figure 7.  Staining of apoptotic Hb60 cells with anti-Ku, histone, and 
Sm mAbs. HL-60  ceUs were double stained with PI (DNA content) and 
the IgG2a mAbs 162 (anti-Ku), BM6.5 (anti-histone H1), Y2 (anti-Sin 
B'/B and D), or PAbl01 (isotype control, anti-SV40 large T antigen), 
followed  by FITC-conjugated  goat anti-mouse IgG2a. Samples  were ana- 
lyzed by FACSCAN  |  (Becton Dickinson and Co.), placing FITC gates 
on the subdiploid (apoptotic) region of the DNA histogram (left) or on 
nonapoptotic cells having G1, S, or G2/M DNA content (right). (Top) 
FITC fluorescence  histogram  of  anti-Ku  (162,  solid  line) vs control (PAbl01, 
dotted line) staining of apoptotic  (left) and nonapoptotic  (right) ceils. (M/dd/e) 
FITC fluorescence  histogram of anti-histone (BM6.5, solid line) vs control 
(dotted  line)  staining  of  apoptotic  vs nonapoptotic  cells. (Bottom)  FITC fluores- 
cence histogram of anti-Sin (Y2, solid line) vs control (dotted  line) staining 
of apoptotic vs nonapoptotic cells. 
with anti-Ku mAbs. After treatment with 0.5% sodium azide, 
necrotic cells were identified by PI uptake followed by meth- 
anol fixation and were found to stain positively with mAb 
162 (data not shown), suggesting that the loss of Ku staining 
was not due to nuclear leakage or proteolysis as a nonspecific 
consequence of cell death. 
Half-life ofKu andp350.  The loss of Ku in apoptotic cells 
might reflect either a shutdown of de novo synthesis of pro- 
teins with  a relatively short half-life or else active degrada- 
tion of proteins with a long half-life. To distinguish between 
these possibilities,  the turnover of Ku and p350 was exam- 
ined in K562 (human erythroleukemia) cells by pulse labeling 
and immunoprecipitating cell extracts derived from aliquots 
of cells obtained after 1, 2, 3, 4, or 5 d of chase (Fig. 8) using 
an excess of mAb 162 (anti-Ku) or 25-4 (anti-p350). It should 
be noted that each extract was derived from an equal number 
2054  Loss of Ku Antigen during Apoptosis at different time points during chase revealed little turnover 
of the newly synthesized Ku up to 5 d after its synthesis (Fig. 
8 B), findings which were consistent with our previous ob- 
servations (15). Likewise, little turnover of newly synthesized 
p350 was seen until the fifth day of chase (Fig. 8 B). Studies 
of the turnover of Ku and p350 in resting and PHA-stimulated 
PBLs indicated that the antigens were not synthesized at de- 
tectable levels in resting PBLs, whereas all three proteins were 
synthesized in mitogen-activated PBLs. The turnover of the 
three proteins was more rapid in PHA-activated PBLs than 
in K562, but considerable amounts of Ku and p350 antigen 
remained at 5 d (data not shown). The interpretation of Ku 
turnover in PHA-activated PBLs was complicated, however, 
by Ku loss related to the high level of programmed cell death 
in these cells. Taken together, these data indicated that the 
rate of turnover of Ku and p350 was too slow to account 
for the disappearance of Ku during apoptosis. 
Figure  8.  Turnover  of Ku and p350 antigens. K562 cells were pulse 
labeled with 3sS and divided  into equal aliquots. Cells were harvested  at 
0, 1, 2, 3, 4, and 5 d after  pulse labeling, and extracts  were analyzed  for 
Ku or p350 by immunoprecipitation  with mAbs 162 or 25-4, respectively. 
(A) Autoradiographs  showing  turnover  p70 and pS0 bands immunopre- 
cipitated by mAb 162 (right) or p350 band immunoprecipitated  by 25-4 
(left). Delayed  association  of  pulse-labeled  p350 with p70/p80 heterodimer 
and lower intensity of p70 than of p80 after pulse labeling (right, lane 
0) due to an endogenous  pool of free p70 subunits have been reported 
previously  (15). (/~ top) Quantitation  of  radioactivity  remaining  associated 
with p70 (open circles)  and pS0 (closed  circles)  over  time. (Bottom)  Quantita- 
tion of p350 radioactivity  over time. 
of cells pulse labeled at day 0, and that the total number of 
cells per flask increased with time because of continued cell 
proliferation during chase. Immunoprecipitations of cell ex- 
tracts obtained 0-5  d  after pulse labeling revealed  that the 
turnover of both Ku and p350 is slow (Fig. 8 A). Quantita- 
tion of the amount of pulse-labeled p70 and p80 remaining 
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Discussion 
The present studies indicate that mature peripheral blood 
neutrophils do not express the p70 Ku, p80 Ku, or p350 anti- 
gens, as determined by both the lack of fluorescent staining 
and the absence of the protein subunits by Western blot anal- 
ysis and ELISA. In contrast, the promyelocytic  leukemia line 
HL-60 and PBLs both expressed Ku antigen but lost it during 
programmed cell death. 
Mechanism  of  Ku Disappearance in Neutrophils.  Stability of 
the Ku antigen has been noted previously in human epidermal 
basal cells, which contain a significant amount of Ku but do 
not synthesize it (12). The present studies suggest that the 
half-life of Ku antigen in K562 cells is >5 d (Fig.  5). Since 
the postmitotic life span of neutrophils is ,,06.5 d and their 
half-life  in the blood is 'o10 h  (34),  it is unlikely that  the 
absence of Ku in neutrophils was the consequence of normal 
Ku turnover in GO cells. Moreover, the life span of neutro- 
phils is shorter than that of Ku-positive PBLs. The long half- 
life of Ku and the relatively high level of Ku in resting PBLs, 
in contrast to its  absence in short-lived neutrophils,  argue 
that,  although the levels of both p70 and p80 mKNA are 
reduced dramatically in  HL-60  cells  undergoing DMSO- 
induced differentiation toward neutrophils (14),  the disap- 
pearance of Ku protein during myeloid differentiation is a 
consequence of enhanced degradation. In contrast, the dis- 
appearance of c-myc protein during myeloid differentiation 
of HL-60 (27) is mediated largely at the level of transcrip- 
tion, because of its extremely short half-life (35,  36). 
The presence of  Ku antigen in HL-60 cells and its loss during 
terminal differentiation or apoptosis are somewhat reminis- 
cent of the staining pattern of HL-60 for the c-myc protein, 
which has been implicated in some forms of apoptosis (37, 
38). Moreover, resting lymphocytes have low but detectable 
levels of both c-myc (37,  39) and Ku, and the expression of 
both proteins is increased in PHA-stimulated PBLs  (refer- 
ence 39 and Fig.  5). Expression of bcl-2 prevents apoptosis 
induced by c-myc (40) and is restricted to early myeloid cells 
(41, 42).  The absence of bcl-2 in mature neutrophils is also reminiscent of the expression of Ku reported here. It is in- 
teresting to note that, like Ku antigen and c-myc, bcl-2 is 
normally expressed  in  quiescent circulating lymphocytes, 
which is consistent with a role of bcl-2 in maintaining lym- 
phocyte survival  (43). 
Association of Ku Degradation with Apoptosis.  The similar 
patterns of Ku and bcl-2 protein expression in lymphocytes 
and myeloid cells raise the possibility that, like bcl-2, Ku an- 
tigen might play a role in some forms of apoptosis. The ab- 
sence of both Ku (Fig. 6) and p350 in apoptotic HL-60 cells 
and PBLs (Fig. 5) is consistent with the possibility that Ku 
is involved in regulating programmed cell death, possibly 
acting as an inhibitor. However, since apoptosis generally ac- 
companies terminal granulocytic differentiation (29, 30), and, 
in culture, "~5% of ilL-60 cells exhibit spontaneous differen- 
tiation into myelocytes, metamyelocytes,  or banded or seg- 
mented neutrophils (27), it is difficult to completely exclude 
the possibility that the loss of Ku was a consequence of differen- 
tiation. However, terminally differentiated epithelial cells and 
other types of cells contain high levels of Ku (references 12 
and 44 and Reeves, W.  H., unpublished data),  suggesting 
that, if loss of Ku is a differentiation marker, it must be rela- 
tively specific for the myeloid lineage. 
The absence of Ku in apoptotic PBLs provides strong evi- 
dence that disappearance of Ku is a marker of apoptosis rather 
than of terminal differentiation, and it suggests that the degra- 
dation of Ku is not a unique feature of apoptosis in myeloid 
cells. The absence of Ku in the apoptotic cell population 
resulting from activation with the T cell mitogen PHA sug- 
gests that the Ku-deficient lymphocytes may have been pre- 
dominantly T cells. However, further studies will be needed 
to determine whether Ku loss is associated with apoptosis 
in T lymphocytes, B lymphocytes, or both. It will also be 
of interest to determine whether the kinetics of Ku disap- 
pearance in lymphocytes and neutrophils undergoing apop- 
tosis is similar. 
There are several potential explanations for the loss of Ku 
from apoptotic cells. Loss of Ku from apoptotic cells due to 
nonspecific nuclear leakage or proteolysis is unlikely because 
other nuclear DNA-binding (histone H1) and non-DNA- 
binding (Sin B'/B and D) proteins were detected readily in 
cells undergoing apoptosis (Fig. 7). Moreover, necrotic cells 
stained positively for Ku despite their permeability to PI. It 
is also possible that Ku is redistributed within apoptotic cells, 
such that it is more readily extracted from the cell. For ex- 
ample, cell cycle-regulated redistribution of PCNA is respon- 
sible for the apparent lack of that antigen in resting cells (31). 
Ku antigen dissociates from condensing chromosomes during 
early prophase (45), raising the possibility that the chromatin 
condensation characteristic  of apoptosis likewise causes Ku 
to dissociate from chromosomes, making it more readily ex- 
tracted during fixation.  Although this possibility cannot be 
excluded completely, Ku staining was absent in apoptotic cells 
fixed with paraformaldehyde,  whereas PCNA is retained in 
resting  cells  fixed  in  this  manner  (31). In  addition,  im- 
munofluorescence studies indicate that Ku is not extracted 
from the cytoplasm of mitotic HeLa cells during methanol 
fixation (reference 45 and Ajmani, A.K., unpublished obser- 
vations).  The most likely explanation for the loss of Ku in 
apoptotic HL-60 cells and lymphocytes is that enhanced Ku 
degradation accompanies and/or plays a role in some forms 
of apoptosis. In view of the enhanced susceptibility of DNA- 
bound pS0 Ku to site-specific proteolysis (46), it is possible 
that DNA fragmentation accompanying apoptosis increases 
the fraction of Ku bound to DNA, thereby accelerating its 
degradation by proteases involved in programmed cell death, 
such as IL-1/3-converting enzyme (47, 48) or calpain (49). 
However, it should be noted that nearly all peripheral blood 
neutrophils in the present study had a G1/G0 DNA content, 
suggesting that they had not yet begun to undergo apop- 
tosis, a finding which is in agreement with previous observa- 
tions that apoptotic neutrophils are removed rapidly from 
the circulation (50).  Thus, the absence of Ku and p350 in 
neutrophils suggests that these antigens are degraded either 
before onset of apoptosis or at an early stage before DNA 
fragmentation and intracellular proteolysis.  Further studies 
will be necessary to determine whether the loss of Ku pre- 
cedes apoptosis in all cell types or if the early loss of Ku is 
an event unique to the differentiation ofneutrophils, rendering 
these cells more susceptible to the initiation of apoptosis. In 
view of the recently described role of Ku antigen in double- 
strand DNA break repair (8-11), degradation of Ku during 
apoptosis may prevent the repair of the double-strand DNA 
breaks  that are a central feature of programmed cell death 
(51). The inability of mature neutrophils, unhke resting PBLs, 
to repair DNA strand breaks induced by y  irradiation (52) 
may be related, in part, to the absence of Ku. Thus, the loss 
of Ku antigen and/or p350 may be an important feature of 
certain forms of apoptosis that allows nucleases to cleave nu- 
clear DNA unopposed by DNA repair mechanisms. 
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